News

News 31.05.2022 Schlieren (Zurich), Switzerland, May 31, 2022 – Kuros Biosciences (“Kuros” or the “Company”), a leader in next generation bone graft technologies, announced today promising preliminary results from the first of its five planned randomized controlled trials for its MagnetOs family, comparing MagnetOs Granules to the gold standard of autograft bone. Data from...

News 18.05.2022 Schlieren (Zurich), Switzerland, May 18, 2022 – Kuros Biosciences (“Kuros” or the “Company”), a leader in next generation bone graft technologies, announced today the commercial launch of MagnetOs Easypack Putty in the U.S., at the 22nd Annual Meeting of the International Society for the Advancement of Spine Surgery (ISASS), held in...

News 17.05.2022 ZURICH-SCHLIEREN, Switzerland, May 16, 2022 – DiNAQOR announced today the launch of DiNAQOR DiNAMIQS, a biomanufacturing subsidiary, that will accelerate development timelines and reduce costs and risk for genetic medicine companies bringing new treatments to market. DiNAQOR DiNAMIQS is based in the company’s state-of-the-art, 1,200-square-meter (13,000 square feet) manufacturing facility in...

News 13.05.2022 ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., May 12, 2022 (GLOBE NEWSWIRE) --  Ad hoc announcement pursuant to Art. 53 LR: Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, today announced its interim management statement for the quarter ending...

News 11.05.2022 Zurich-Schlieren, Switzerland and Avellino, Italy, May 11, 2022 – Diagnostica Medica of Mercogliano (Avellino), Italy, and Proteomedix, the Swiss cancer diagnostics company, announced today that Proclarix®, a new blood test for the management of prostate cancer patients, has been introduced in the routine of the laboratory that is part of...